Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026)

Updated

Amneal Pharmaceuticals' EBIT came in at $95.42 million for Q3 2026, up 35.6% from $70.34 million a year earlier but down 26.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Amneal Pharmaceuticals reported EBIT of $478.99 million, up 33.8% year-over-year; for FY2025, it was $394.1 million, up 58.1% from FY2024.

  • EBIT carries a five-year compound annual growth rate of 34.0% (FY2020 to FY2025).
  • Going back by year, EBIT was $249.33 million in FY2024 (+22.0%), $204.37 million in FY2023, -$94.93 million in FY2022 and $152.72 million in FY2021 (+67.5%).
  • The five-year range for quarterly EBIT is -$198.62 million (Q2 2022) to $141.77 million (Q1 2026).
  • Year-over-year, EBIT has increased for four consecutive quarters, with growth averaging 81.6% over the last seven quarters.
  • The fastest year-over-year change in EBIT over five years came in Q4 2024 (growth of 434.0%), and the weakest in Q4 2023 (a decline of 60.6%).
  • Business Quant data shows AMRX's EBIT at $129.77 million (Q2 2026), $141.77 million (Q1 2026) and $112.03 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 6.18 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.27 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.39 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 3.46 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.47 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 95.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 95.42 Mn
Jun 30, 2026 129.77 Mn
Mar 31, 2026 141.77 Mn
Dec 31, 2025 112.03 Mn
Sep 30, 2025 70.34 Mn
Jun 30, 2025 111.37 Mn
Mar 31, 2025 100.35 Mn
Dec 31, 2024 75.79 Mn
Sep 30, 2024 88.81 Mn
Jun 30, 2024 95.47 Mn
Mar 31, 2024 -10.75 Mn
Dec 31, 2023 14.19 Mn
Sep 30, 2023 75.65 Mn
Jun 30, 2023 80.08 Mn
Mar 31, 2023 34.45 Mn
Dec 31, 2022 36.03 Mn
Sep 30, 2022 44.35 Mn
Jun 30, 2022 -198.62 Mn
Mar 31, 2022 23.31 Mn
Dec 31, 2021 11.18 Mn
API Access

Amneal Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=AMRX&period=max&api_key=YOUR_API_KEY